Abstract: The present disclosure provides an obstacle type recognizing method and apparatus, a device and a storage medium, wherein the method comprises: obtaining 3D point cloud data corresponding to a to-be-recognized obstacle; mapping the 3D point cloud data and its dimension data to a four-dimensional array; recognizing a type of the obstacle through a deep learning algorithm based on the four-dimensional array. The solution of the present disclosure can be applied to determine the type of the obstacle such as a person, a bicycle or a motor vehicle; and recognize a small-sized vehicle, a medium-sized vehicle and a large-sized vehicle; and improve the accuracy of a recognition result.

Abstract: The present disclosure provides a method and apparatus for anti hacker's hijacking of an autonomous vehicle, a device and a storage medium, wherein the method comprises monitoring an autonomous vehicle's running data; determining whether the autonomous vehicle is hijacked by a hacker according to a monitoring result and a preset rule; activating an anti-hijack emergency handling operation if it is determined that the autonomous vehicle is hijacked by the hacker. The solution of the present disclosure may be applied to improve safety of the autonomous vehicle.

Abstract: The present disclosure provides an obstacle type recognizing method and apparatus, a device and a storage medium, wherein the method comprises: obtaining 3D point cloud data corresponding to a to-be-recognized obstacle; mapping the 3D point cloud data and its dimension data to a four-dimensional array; recognizing a type of the obstacle through a deep learning algorithm based on the four-dimensional array. The solution of the present disclosure can be applied to determine the type of the obstacle such as a person, a bicycle or a motor vehicle; and recognize a small-sized vehicle, a medium-sized vehicle and a large-sized vehicle; and improve the accuracy of a recognition result.

Abstract: The present disclosure provides a method and apparatus for anti hacker's hijacking of an autonomous vehicle, a device and a storage medium, wherein the method comprises monitoring an autonomous vehicle's running data; determining whether the autonomous vehicle is hijacked by a hacker according to a monitoring result and a preset rule; activating an anti-hijack emergency handling operation if it is determined that the autonomous vehicle is hijacked by the hacker. The solution of the present disclosure may be applied to improve safety of the autonomous vehicle.

Abstract: The present disclosure provides methods useful for prolonging the survival of an allograft organ in a recipient mammal. The methods include administration of an anti-CD200 antibody or a CD200-binding fragment of the antibody. The disclosure also provides biomarkers, a change in one or more of which indicates that an anti-CD200 antibody has produced a desired immunomodulatory effect in a mammal. Also featured are pharmaceutical compositions, kits, and solutions that contain at least one anti-CD200 antibody and are useful in the methods described herein.

Abstract: Methods of prolonging survival of a transplanted organ, as well as methods of preventing or attenuating rejection of a transplanted organ are provided. These methods involve contacting the organ with an inhibitor of complement activity (e.g., a complement inhibitor that has a maximum molecular weight of 70 kDa and/or a half-life shorter than 10 days, such as a CR2-FH fusion protein or a single chain anti-C5 antibody), prior to transplantation The methods also include administering to the allotransplant recipient an inhibitor of complement activity together with one or more immunosuppressants. A pretreatment with an alternative complement inhibitor was found to be effective in improving graft survival and decreasing ischemia-reperfusion injury in animal.

Abstract: The present disclosure provides methods useful for prolonging the survival of an allograft organ in a recipient mammal. The methods include administration of an anti-CD200 antibody or a CD200-binding fragment of the antibody. The disclosure also provides biomarkers, a change in one or more of which indicates that an anti-CD200 antibody has produced a desired immunomodulatory effect in a mammal. Also featured are pharmaceutical compositions, kits, and solutions that contain at least one anti-CD200 antibody and are useful in the methods described herein.